Loading...

PODCAST

The GMP Insider

GMP Insider is your go-to podcast for practical insights into pharmaceutical quality, Good Manufacturing Practices (GMP), and regulatory compliance. Designed for quality professionals, manufacturing teams, and pharma leaders, this show breaks down complex regulations into clear, real-world guidance. Each episode explores topics like audits, CAPA, data integrity, quality systems, validation, and global regulatory expectations — all with a focus on protecting patients and building strong quality

science life sciences

All Episodes

18:34

Why Retraining Is Not Always the Right CAPA

The GMP Insider ·

2026/04/12

Retraining is one of the most common corrective actions used in pharmaceutical investigations — but it is often applied even when the true issue is not a knowledge gap. In this episode of The GMP Insider, we explore why awareness training, reinforcement discussions, and SOP reviews are frequently overused as CAPAs, even when the underlying problem is process design, unclear procedures, or weak system controls. Discussion topics include:• When retraining is appropriate• Why awareness

en-us

14:59

Why People Stay Silent: The Hidden Risk in Quality...

The GMP Insider ·

2026/03/29

One of the clearest indicators of a weak quality culture is when employees hesitate to report problems.In strong organizations, people raise deviations, near misses, process gaps, and data concerns early because they understand that the purpose is to improve the system, not assign blame. In this episode of The GMP Insider, we examine why individuals often stay silent about quality issues and how this creates significant organizational risk. Discussion topics include:• The fear of blame and

en-us

19:42

“We’ve Always Done It This Way”: The Hidden Risk in...

The GMP Insider ·

2026/03/29

“We've always done it this way” is one of the most dangerous mindsets in pharmaceutical quality systems. As processes evolve, regulations change, and risks shift, organizations can unintentionally continue relying on habits rather than evidence. Over time, temporary fixes become permanent, recurring issues lose urgency, and workarounds become normalized. In this episode of The GMP Insider, we examine how quality systems drift out of control when outdated practices go

en-us

10:54

Activity vs Effectiveness: What FDA Really Wants to See

The GMP Insider ·

2026/03/29

In Quality Assurance, activity is often mistaken for effectiveness. CAPAs are closed, training is completed, and SOPs are revised — but the underlying system may still remain weak. In this episode of The GMP Insider, we explore why FDA inspections focus not only on whether actions were taken, but on whether those actions actually improved control and reduced risk. Discussion topics include:• The difference between completing actions and achieving effectiveness• Why CAPA closure does

en-us

19:14

Beyond Human Error: Finding the Real Root Cause in...

The GMP Insider ·

2026/03/29

“Human error” is one of the most common conclusions in pharmaceutical quality investigations — but it is rarely the true root cause. In this episode of The GMP Insider, we explore why organizations often stop too early in root cause analysis and how this limits long-term system improvement. Rather than focusing on who made the mistake, strong quality systems ask what conditions allowed the mistake to happen. Discussion topics include:• Why “human error” is often an

en-us

22:07

FDA Inspections of Biologics: Understanding the...

The GMP Insider ·

2026/03/29

Biological drug products present unique manufacturing and quality challenges due to their complexity, aseptic processing requirements, and critical public health impact. In this episode of The GMP Insider, we explore how the FDA conducts inspections of biologics manufacturers through a systems-based, risk-management approach. The FDA's biologics inspection program covers vaccines, blood derivatives, allergenic products, recombinant therapies, gene therapies, and cellular products. Manufacturers are

en-us

19:40

When AI Meets FDA: Credibility Over Capability in Pharma

The GMP Insider ·

2026/03/29

Artificial Intelligence is becoming increasingly important across the pharmaceutical industry, influencing clinical trials, manufacturing, pharmacovigilance, and regulatory submissions. In this episode of The GMP Insider, we explore the FDA's emerging expectations for AI in regulatory decision-making and why credibility matters more than capability. The FDA's latest guidance introduces a risk-based credibility framework, emphasizing that AI models must be validated within a clearly defined Context

en-us

20:13

Responding to FDA Form 483: New FDA Guidance Explained

The GMP Insider ·

2026/03/08

The FDA has issued new guidance to help drug manufacturers respond effectively to FDA Form 483 inspection observations at the conclusion of CGMP inspections.An FDA Form 483 documents conditions or practices observed by investigators that may represent potential violations of regulatory requirements, but it does not represent the Agency's final compliance determination. In this episode of The GMP Insider, we explore how pharmaceutical organizations should approach the post-inspection response

en-us

16:08

Process Optimization and Endurance: Lessons from Ford...

The GMP Insider ·

2026/03/02

Ford v Ferrari offers a compelling analogy for pharmaceutical manufacturing and quality system maturity. While the film focuses on building a race-winning car, the deeper lesson centers on disciplined engineering, controlled experimentation, and balancing speed with reliability.In this episode of The GMP Insider, we explore how the principles demonstrated in the film reflect core pharmaceutical quality practices. Key themes include:• Data-driven process optimization• Structured change

en-us

18:07

Continuous Improvement in Pharma: Lessons from The...

The GMP Insider ·

2026/03/01

Continuous improvement is a foundational principle of modern pharmaceutical quality systems, yet its mindset is often best illustrated through real-world storytelling. In this episode of The GMP Insider, we examine how the problem-solving approach in The Martian reflects the core elements of pharmaceutical Quality culture — data-driven decisions, disciplined documentation, controlled experimentation, and cross-functional collaboration. Key themes include:• Using measurable data instead of

en-us

19:47

A Quality Leader’s Guide to AI Governance in Pharma

The GMP Insider ·

2026/03/01

Artificial Intelligence is increasingly embedded across pharmaceutical processes — from clinical analytics and pharmacovigilance to manufacturing optimization. However, AI adoption in regulated environments requires more than technical implementation; it demands structured governance. In this episode of The GMP Insider, we examine how Quality leaders can prepare for AI integration within GxP systems. Discussion topics include:• Defining intended use and GxP impact• Evolving

en-us

18:43

The Architecture of Trust: AI Governance in...

The GMP Insider ·

2026/03/01

Artificial Intelligence is rapidly integrating across pharmaceutical development, manufacturing, and post-market safety systems. While AI offers significant efficiency gains, its use within regulated environments demands robust governance, validation, and oversight. In this episode of The GMP Insider, we examine the opportunities, risks, and responsibilities associated with AI implementation in pharma quality systems. Discussion topics include:• AI applications across drug discovery, clinical

en-us

18:31

Apollo 13 and the Art of Root Cause Analysis in...

The GMP Insider ·

2026/02/23

The Apollo 13 mission offers a powerful example of structured problem-solving — a mindset that closely mirrors effective deviation management and Root Cause Analysis within pharmaceutical quality systems.In this episode of The GMP Insider, we explore how NASA's response to a critical system failure reflects the principles of strong investigations, risk-based decision making, and CAPA effectiveness. Key discussion areas include:• Defining deviations with clarity and objectivity•

en-us

17:44

The Foundations of Trust in Clinical Quality Assurance

The GMP Insider ·

2026/02/22

Clinical Quality Assurance plays a critical role in safeguarding the credibility of clinical trial data and the safety of participants during drug development. While often associated with audits and GCP inspections, Clinical QA extends far beyond compliance checks. In this episode of The GMP Insider, we explore how Clinical QA supports quality systems throughout development by ensuring ethical conduct, reliable data, and consistent processes. Key discussion areas include:• GCP compliance and

en-us

20:13

Guardian of Patient Safety: The Essence of...

The GMP Insider ·

2026/02/22

Pharmacovigilance Quality extends far beyond reporting timelines. Its primary purpose is ensuring that safety systems consistently capture, evaluate, and communicate real-world patient safety information after product approval. In this episode of The GMP Insider, we examine the unique role PV Quality plays within the pharmaceutical lifecycle and how it differs from Clinical and Commercial QA functions. Key discussion areas include:• Oversight of safety case processing and data integrity•

en-us

5:51

Foundations of Excellence: Mastering Early Career...

The GMP Insider ·

2026/02/22

The early years in Quality Assurance shape how professionals think about risk, systems, and compliance throughout their careers. While learning procedures and documentation is essential, long-term growth comes from developing strong analytical and communication skills. In this episode of The GMP Insider, we discuss the core capabilities new QA professionals should build during their first three years in the pharmaceutical industry. Key focus areas include:• Risk-based thinking and system

en-us

4:51

Transitioning Across Pharma QA Roles: Clinical,...

The GMP Insider ·

2026/02/22

Quality careers in pharma often evolve across multiple stages of the product lifecycle. While Clinical QA, Commercial QA, and Pharmacovigilance QA share a strong quality foundation, each role requires understanding a distinct risk environment. In this episode of The GMP Insider, we discuss how QA professionals can transition between these roles and what mindset shifts are required to succeed. Topics include:• Moving from GMP to GCP thinking in Clinical QA• Shifting toward process control

en-us

17:10

Clinical QA, Commercial QA, and PV QA: Three Roles,...

The GMP Insider ·

2026/02/22

Clinical QA, Commercial QA, and Pharmacovigilance QA represent three distinct perspectives within pharmaceutical quality, each aligned with a different stage of the product lifecycle. In this episode of The GMP Insider, we explore how Clinical QA safeguards data integrity during development, Commercial QA ensures consistent product quality in manufacturing, and PV QA monitors patient safety after market approval. Key discussion points include:• GCP oversight and clinical trial auditing•

en-us

16:08

From Compliance to Control: The Mindset Shift in...

The GMP Insider ·

2026/02/13

One of the most significant milestones in a QA career is moving beyond compliance thinking toward system control. While compliance ensures that requirements and documentation exist, control evaluates whether processes behave predictably and risks are actively managed.In this episode of The GMP Insider, we explore why systems can appear compliant yet remain unstable, and how quality professionals grow when they begin focusing on variability, recurrence, trend analysis, and long-term

en-us

16:05

Data Integrity by Design: Building Systems That...

The GMP Insider ·

2026/02/13

Data integrity is fundamentally a system design challenge rather than a documentation exercise. Most integrity risks emerge not from intentional falsification, but from processes that rely heavily on manual entries, informal workarounds, and individual memory. In this episode of The GMP Insider, we discuss how the FDA evaluates whether systems are designed to prevent, detect, and correct errors — emphasizing controls over trust. Key topics include:• How system design influences data

en-us

68 results

Similar Podcasts

The Deep Dive Lab: Unraveling Materials Science

Son Hoang

New Books in Political Science

New Books Network

Station 151

Pale Matter | Realm

Beyond the Divide

Koala Moon

StarTalk with Neil deGrasse Tyson

Neil deGrasse Tyson